Role of ABCG2 in transport of the mammalian lignan enterolactone and its secretion into milk in abcg2 knockout mice

Drug Metabolism and Disposition

Volumn 42, Issue 5, 2014, Pages 943-946

  Miguel, Verónica ^a   Otero, Jon Andoni ^b   García Villalba, Rocío ^a   Tomás Barberán, Francisco ^a   Espín, Juan Carlos ^a   Merino, Gracia ^a,b   Álvarez, Ana I ^a,c,d  

^a UNIVERSITY OF LEÓN   (Spain)

^b Instituto de Desarrollo Ganadero y Sanidad Animal   (Spain)

^c Research Group on Quality   (Spain)

^d RESEARCH GROUP ON QUALITY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,4,6,7,12,12A OCTAHYDRO 6 ISOBUTYL 9 METHOXY 1,4 DIOXOPYRAZINO[1',2':1,6]PYRIDO[3,4 B]INDOLE 3 PROPANOIC ACID TERT BUTYL ESTER; BREAST CANCER RESISTANCE PROTEIN; ENTEROLACTONE; MITOXANTRONE; 2,3-BIS(3'-HYDROXYBENZYL)BUTYROLACTONE; 3-(6-ISOBUTYL-9-METHOXY-1,4-DIOXO-1,2,3,4,6,7,12,12A-OCTAHYDROPYRAZINO(1',2'-1,6)PYRIDO(3,4-B)INDOL-3-YL)PROPIONIC ACID TERT-BUTYL ESTER; ABC TRANSPORTER; ABCG2 PROTEIN, HUMAN; ABCG2 PROTEIN, MOUSE; ADENOSINE; GAMMA BUTYROLACTONE; LIGNAN; TUMOR PROTEIN;

ANIMAL CELL; ARTICLE; BLOOD LEVEL; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG TRANSPORT; ENZYME SUBSTRATE; HORMONE RELEASE; HUMAN; KNOCKOUT MOUSE; MILK; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CHEMISTRY; DOG; ENZYME SPECIFICITY; FEMALE; GENETICS; MDCK CELL LINE; METABOLISM; PHYSIOLOGY; SECRETION (PROCESS); TRANSPORT AT THE CELLULAR LEVEL;

4-BUTYROLACTONE; ADENOSINE; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; DOGS; FEMALE; LIGNANS; MADIN DARBY CANINE KIDNEY CELLS; MICE; MICE, KNOCKOUT; MILK; MITOXANTRONE; NEOPLASM PROTEINS; SUBSTRATE SPECIFICITY;

EID: 84898815955     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.113.055970     Document Type: Article

References (35)

1. Adlercreutz H (2002) Phyto-oestrogens and cancer. Lancet Oncol 3:364-373.
2. Adolphe JL, Whiting SJ, Juurlink BH, Thorpe LU, and Alcorn J (2010) Health effects with consumption of the flax lignan secoisolariciresinol diglucoside. Br J Nutr 103:929-938.
3. Allen JD, van Loevezijn A, Lakhai JM, van der Valk M, van Tellingen O, Reid G, Schellens JH, Koomen GJ, and Schinkel AH (2002) Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. Mol Cancer Ther 1:417-425.
4. Álvarez AI, Vallejo F, Barrera B, Merino G, Prieto JG, Tomás-Barberán F, and Espín JC (2011) Bioavailability of the glucuronide and sulfate conjugates of genistein and daidzein in breast cancer resistance protein 1 knockout mice. Drug Metab Dispos 39:2008-2012.
5. Antignac J, Cariou R, Le-Bizec B, and André F (2004) New data regarding phytoestrogens content in bovine milk. Food Chem 87:275-281.
6. AzradM, VollmerRT, Madden J, Dewhirst M, Polascik TJ, SnyderDC,RuffinMT,Moul JW, Brenner DE, and Demark-Wahnefried W (2013) Flaxseed-derived enterolactone is inversely associated with tumor cell proliferation in men with localized prostate cancer. J Med Food 16:357-360.
7. Bolca S, Urpi-Sarda M, Blondeel P, Roche N, Vanhaecke L, Possemiers S, Al-Maharik N, Botting N, De Keukeleire D, and Bracke M, et al. (2010) Disposition of soy isoflavones in normal human breast tissue. Am J Clin Nutr 91:976-984.
8. Corsini E, Dell'Agli M, Facchi A, De Fabiani E, Lucchi L, Boraso MS, Marinovich M, and Galli CL (2010) Enterodiol and enterolactone modulate the immune response by acting on nuclear factor-kappaB (NF-kappaB) signaling. J Agric Food Chem 58:6678-6684.
9. Crozier A, Jaganath IB, and Clifford MN (2009) Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep 26:1001-1043.
10. Del Rio D, Rodriguez-Mateos A, Spencer JP, Tognolini M, Borges G, and Crozier A (2013) Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal 18:1818-1892.
11. Guglielmini P, Rubagotti A, and Boccardo F (2012) Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study. Breast Cancer Res Treat 132:661-668.
12. Högger P (2013) Nutrition-derived bioactive metabolites produced by gut microbiota and their potential impact on human health. Nutri Med 1:1-32.
13. Hu C, Yuan YV, and Kitts DD (2007) Antioxidant activities of the flaxseed lignan secoisolariciresinol diglucoside, its aglycone secoisolariciresinol and the mammalian lignans enterodiol and enterolactone in vitro. Food Chem Toxicol 45:2219-2227.
14. Huls M, Brown CD, Windass AS, Sayer R, van den Heuvel JJ, Heemskerk S, Russel FG, and Masereeuw R (2008) The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane. Kidney Int 73:220-225.
15. Jonker JW, Merino G, Musters S, van Herwaarden AE, Bolscher E, Wagenaar E, Mesman E, Dale TC, and Schinkel AH (2005) The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk. Nat Med 11:127-129.
16. Kitts DD, Yuan YV, Wijewickreme AN, and Thompson LU (1999) Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone. Mol Cell Biochem 202:91-100.
17. Krumpochova P, Sapthu S, Brouwers JF, de Haas M, de Vos R, Borst P, and van de Wetering K (2012) Transportomics: screening for substrates of ABC transporters in body fluids using vesicular transport assays. FASEB J 26:738-747.
18. Kuijsten A, Arts IC, Vree TB, and Hollman PC (2005) Pharmacokinetics of enterolignans in healthy men and women consuming a single dose of secoisolariciresinol diglucoside. J Nutr 135:795-801.
19. Kuijsten A, Arts IC, Hollman PC, van't Veer P, and Kampman E (2006) Plasma enterolignans are associated with lower colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 15:1132-1136.
20. Lampe JW, Atkinson C, and Hullar MA (2006) Assessing exposure to lignans and their metabolites in humans. J AOAC Int 89:1174-1181.
21. Merino G, Jonker JW, Wagenaar E, Pulido MM, Molina AJ, Alvarez AI, and Schinkel AH (2005) Transport of anthelmintic benzimidazole drugs by breast cancer resistance protein (BCRP/ABCG2). Drug Metab Dispos 33:614-618.
22. Merino G, Alvarez AI, Pulido MM, Molina AJ, Schinkel AH, and Prieto JG (2006) Breast cancer resistance protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion. Drug Metab Dispos 34:690-695.
23. Otero JA, Real R, de la Fuente A, Prieto JG, Marqués M, Álvarez AI, and Merino G (2013) The bovine ATP-binding cassette transporter ABCG2 Tyr581Ser single-nucleotide polymorphism increases milk secretion of the fluoroquinolone danofloxacin. Drug Metab Dispos 41:546-549.
24. Pavek P, Merino G, Wagenaar E, Bolscher E, Novotna M, Jonker JW, and Schinkel AH (2005) Human breast cancer resistance protein: interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6- phenylimidazo(4,5-b)pyridine, and transport of cimetidine. J Pharmacol Exp Ther 312:144-152.
25. Real R, González-Lobato L, Baro MF, Valbuena S, de la Fuente A, Prieto JG, Alvarez AI, Marques MM, and Merino G (2011) Analysis of the effect of the bovine adenosine triphosphate-binding cassette transporter G2 single nucleotide polymorphism Y581S on transcellular transport of veterinary drugs using new cell culture models. J Anim Sci 89:4325-4338.
26. Robey RW, To KK, Polgar O, Dohse M, Fetsch P, Dean M, and Bates SE (2009) ABCG2: a perspective. Adv Drug Deliv Rev 61:3-13.
27. Tan KW, Li Y, Paxton JW, Birch NP, and Scheepens A (2013) Identification of novel dietary phytochemicals inhibiting the efflux transporter breast cancer resistance protein (BCRP/ABCG2). Food Chem 138:2267-2274.
28. van de Wetering K and Sapthu S (2012) ABCG2 functions as a general phytoestrogen sulfate transporter in vivo. FASEB J 26:4014-4024.
29. van Herwaarden AE, Jonker JW, Wagenaar E, Brinkhuis RF, Schellens JH, Beijnen JH, and Schinkel AH (2003) The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine. Cancer Res 63:6447-6452.
30. van Herwaarden AE and Schinkel AH (2006) The function of breast cancer resistance protein in epithelial barriers, stem cells and milk secretion of drugs and xenotoxins. Trends Pharmacol Sci 27:10-16.
31. van Herwaarden AE, Wagenaar E, Merino G, Jonker JW, Rosing H, Beijnen JH, and Schinkel AH (2007) Multidrug transporter ABCG2/breast cancer resistance protein secretes riboflavin (vitamin B2) into milk. Mol Cell Biol 27:1247-1253.
32. Vlaming ML, Lagas JS, and Schinkel AH (2009) Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice. Adv Drug Deliv Rev 61:14-25.
33. Ward WE, Yuan YV, Cheung AM, and Thompson LU (2001) Exposure to flaxseed and its purified lignan reduces bone strength in young but not older male rats. J Toxicol Environ Health A 63:53-65.
34. Zhou L, Naraharisetti SB, Wang H, Unadkat JD, Hebert MF, and Mao Q (2008) The breast cancer resistance protein (Bcrp1/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: an Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study. Mol Pharmacol 73:949-959.
35. Zhu W, Xu H, Wang SW, and Hu M (2010) Breast cancer resistance protein (BCRP) and sulfotransferases contribute significantly to the disposition of genistein in mouse intestine. AAPS J 12:525-536.